Advanced

TRITON and Beyond: New Insights into the Profile of Prasugrel.

Jakubowski, Joseph A; Riesmeyer, Jeffrey S; Close, Sandra L; Leishman, Amy G and Erlinge, David LU (2012) In Cardiovascular Therapeutics 30(4). p.174-182
Abstract
Prasugrel, a third-generation thienopyridine antiplatelet agent, demonstrated superior efficacy to clopidogrel but with an increased risk of bleeding in the phase III pivotal registration Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction (TRITON-TIMI 38). This article reviews and discusses select components of a large literature of prasugrel data that has emerged since the TRITON-TIMI 38 (TRITON) study primary disclosure.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Cardiovascular Therapeutics
volume
30
issue
4
pages
174 - 182
publisher
Wiley-Blackwell
external identifiers
  • wos:000305942100002
  • pmid:21883999
  • scopus:84863441791
ISSN
1755-5914
DOI
10.1111/j.1755-5922.2011.00263.x
language
English
LU publication?
yes
id
470202d1-7e7f-4c35-a077-5b7617347a35 (old id 2169234)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/21883999?dopt=Abstract
date added to LUP
2011-10-03 09:12:34
date last changed
2017-01-01 03:10:47
@article{470202d1-7e7f-4c35-a077-5b7617347a35,
  abstract     = {Prasugrel, a third-generation thienopyridine antiplatelet agent, demonstrated superior efficacy to clopidogrel but with an increased risk of bleeding in the phase III pivotal registration Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction (TRITON-TIMI 38). This article reviews and discusses select components of a large literature of prasugrel data that has emerged since the TRITON-TIMI 38 (TRITON) study primary disclosure.},
  author       = {Jakubowski, Joseph A and Riesmeyer, Jeffrey S and Close, Sandra L and Leishman, Amy G and Erlinge, David},
  issn         = {1755-5914},
  language     = {eng},
  number       = {4},
  pages        = {174--182},
  publisher    = {Wiley-Blackwell},
  series       = {Cardiovascular Therapeutics},
  title        = {TRITON and Beyond: New Insights into the Profile of Prasugrel.},
  url          = {http://dx.doi.org/10.1111/j.1755-5922.2011.00263.x},
  volume       = {30},
  year         = {2012},
}